Terminology Service for NFDI4Health

Eribulin/Trastuzumab Regimen

Go to external page http://purl.obolibrary.org/obo/NCIT_C156364


A chemotherapy regimen consisting of eribulin and trastuzumab that may be used in the treatment of recurrent and metastatic HER-2 (EGFR2; ErbB2)-positive breast cancer. [ ]

Term info

Label

Eribulin/Trastuzumab Regimen

Synonyms
  • Eribulin-Trastuzumab
  • Eribulin/Trastuzumab
  • Eribulin/Trastuzumab Regimen
  • Halaven/Herceptin
  • Trastuzumab-Eribulin
  • Trastuzumab/Eribulin
  • Trastuzumab/Eribulin Regimen
Subsets

NCIT_C160952, NCIT_C160950

NCI META CUI

CL563072

Preferred Name

Eribulin/Trastuzumab Regimen

Semantic Type

Therapeutic or Preventive Procedure

code

C156364